Status:
COMPLETED
The SAFE Study: Satisfaction and Adherence to Follow-Up With Colposcopy Exams
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
British Columbia Cancer Agency
Women's Health Research Institute of British Columbia
Conditions:
Uterine Cervical Dysplasia
Uterine Cervix Cancer
Eligibility:
FEMALE
19+ years
Phase:
NA
Brief Summary
This study is intended to improve the patient experience of communication of colposcopy results and follow-up recommendations to patients. Current practice involves results being forwarded from the co...
Detailed Description
Cervical cancer is the second most commonly diagnosed cancer and third leading cause of cancer death in women worldwide. Pre-cancerous cells can be detected with regular Pap smear screening and diagno...
Eligibility Criteria
Inclusion
- Must be 19 years of age or older
- Must be patients presenting for an initial visit at the VGH Colposcopy Clinic
Exclusion
- Inability to speak conversational English- required to complete the questionnaire as well as provide informed consent to participate
- Inability or refusal to provide consent
- Pregnant - pregnant women do not usually have biopsies and their subsequent care may be much different than non-pregnant patients
- Do not have a family physician or referring physician who will provide continuity of care following colposcopy - these patients do not have the option of getting results from a family or referring physician, so they would bias results.
Key Trial Info
Start Date :
July 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
297 Patients enrolled
Trial Details
Trial ID
NCT03296566
Start Date
July 13 2017
End Date
June 30 2018
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vancouver General Hospital - Gordon and Leslie Diamond Health Care Centre
Vancouver, British Columbia, Canada, V5Z 1M9